{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:01:06Z","timestamp":1788454866954,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2021R1A2B5B01002354"],"award-info":[{"award-number":["2021R1A2B5B01002354"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2022R1I1A1A01068782"],"award-info":[{"award-number":["2022R1I1A1A01068782"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2022"],"award-info":[{"award-number":["2022"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.metabol.2025.156323","type":"journal-article","created":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T18:00:38Z","timestamp":1749405638000},"page":"156323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Synergistic effects of C\u2013C chemokine receptor 2 inhibitor and transforming growth factor-\u03b2 type I receptor kinase inhibitor combination in metabolic dysfunction-associated steatohepatitis"],"prefix":"10.1016","volume":"170","author":[{"given":"Su Ho","family":"Jo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Bin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Bong","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choon Hee","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2025.156323_bb0005","doi-asserted-by":"crossref","first-page":"eadi0759","DOI":"10.1126\/scitranslmed.adi0759","article-title":"Found in translation-fibrosis in metabolic dysfunction-associated steatohepatitis (MASH)","volume":"15","author":"Wang","year":"2023","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.metabol.2025.156323_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156080","article-title":"An updated overview on hepatocellular carcinoma in patients with metabolic dysfunction-associated Steatotic liver disease: trends, pathophysiology and risk-based surveillance","volume":"162","author":"Armandi","year":"2025","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2025.156323_bb0015","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1002\/hep.32066","article-title":"Salidroside activates the AMP-activated protein kinase pathway to suppress nonalcoholic steatohepatitis in mice","volume":"74","author":"Hu","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2025.156323_bb0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7570\/jomes23052","article-title":"Metabolic dysfunction-associated Steatotic liver disease (MASLD): a state-of-the-art review","volume":"32","author":"Chan","year":"2023","journal-title":"J Obes Metab Syndr"},{"key":"10.1016\/j.metabol.2025.156323_bb0025","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.metabol.2025.156323_bb0030","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41392-022-01119-3","article-title":"Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver\/steatohepatitis (NAFL\/NASH)","volume":"7","author":"Xu","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.metabol.2025.156323_bb0035","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1074\/jbc.RA118.005761","article-title":"Transforming growth factor beta (TGFbeta) cross-talk with the unfolded protein response is critical for hepatic stellate cell activation","volume":"294","author":"Liu","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2025.156323_bb0040","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.cmet.2024.05.003","article-title":"Metabolic reprogramming in liver fibrosis","volume":"36","author":"Horn","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2025.156323_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155909","article-title":"Kruppel-like factor 10 protects against metabolic dysfunction-associated steatohepatitis by regulating HNF4alpha-mediated metabolic pathways","volume":"155","author":"Pan","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2025.156323_bb0050","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12964-020-00589-8","article-title":"CCL2\/CCR2 signaling in cancer pathogenesis","volume":"18","author":"Hao","year":"2020","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.metabol.2025.156323_bb0055","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): an overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J Interf Cytokine Res"},{"key":"10.1016\/j.metabol.2025.156323_bb0060","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.15252\/emmm.201403967","article-title":"Inflammatory monocytes promote progression of Duchenne muscular dystrophy and can be therapeutically targeted via CCR2","volume":"6","author":"Mojumdar","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.metabol.2025.156323_bb0065","doi-asserted-by":"crossref","first-page":"7388","DOI":"10.1038\/s41467-024-51442-2","article-title":"The TGFbeta type I receptor kinase inhibitor vactosertib in combination with pomalidomide in relapsed\/refractory multiple myeloma: a phase 1b trial","volume":"15","author":"Malek","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2025.156323_bb0070","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1172\/JCI24335","article-title":"CCR2 modulates inflammatory and metabolic effects of high-fat feeding","volume":"116","author":"Weisberg","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2025.156323_bb0075","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.1167\/iovs.09-5110","article-title":"TGF-beta-stimulated CTGF production enhanced by collagen and associated with biogenesis of a novel 31-kDa CTGF form in human corneal fibroblasts","volume":"51","author":"Tall","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.metabol.2025.156323_bb0080","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor-beta in tissue fibrosis","volume":"217","author":"Frangogiannis","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.metabol.2025.156323_bb0085","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1016\/j.cell.2023.07.036","article-title":"TGF-beta signaling in health and disease","volume":"186","author":"Massague","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2025.156323_bb0090","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1091\/mbc.e04-08-0658","article-title":"TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition","volume":"16","author":"Valcourt","year":"2005","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.metabol.2025.156323_bb0095","doi-asserted-by":"crossref","first-page":"46658","DOI":"10.1038\/srep46658","article-title":"Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients","volume":"7","author":"Chiappini","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2025.156323_bb0100","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.bbadis.2014.07.002","article-title":"AMPK activation prevents excess nutrient-induced hepatic lipid accumulation by inhibiting mTORC1 signaling and endoplasmic reticulum stress response","volume":"1842","author":"Li","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2025.156323_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.970292","article-title":"The AMPK pathway in fatty liver disease","volume":"13","author":"Fang","year":"2022","journal-title":"Front Physiol"},{"key":"10.1016\/j.metabol.2025.156323_bb0110","doi-asserted-by":"crossref","first-page":"E775","DOI":"10.1152\/ajpendo.00040.2002","article-title":"ADRP stimulates lipid accumulation and lipid droplet formation in murine fibroblasts","volume":"283","author":"Imamura","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2025.156323_bb0115","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1194\/jlr.M700033-JLR200","article-title":"SREBP-1-independent regulation of lipogenic gene expression in adipocytes","volume":"48","author":"Sekiya","year":"2007","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2025.156323_bb0120","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41573-021-00367-2","article-title":"Lipogenesis inhibitors: therapeutic opportunities and challenges","volume":"21","author":"Batchuluun","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.metabol.2025.156323_bb0125","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1016\/j.molcel.2021.08.015","article-title":"AMPK: restoring metabolic homeostasis over space and time","volume":"81","author":"Trefts","year":"2021","journal-title":"Mol Cell"},{"issue":"210","key":"10.1016\/j.metabol.2025.156323_bb0130","article-title":"Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis","volume":"20","author":"Hansen","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.metabol.2025.156323_bb0135","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.3748\/wjg.v25.i33.4904","article-title":"Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: impact of dietary fat source","volume":"25","author":"Boland","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.metabol.2025.156323_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155200","article-title":"Schisandrin B mitigates hepatic steatosis and promotes fatty acid oxidation by inducing autophagy through AMPK\/mTOR signaling pathway","volume":"131","author":"Yan","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2025.156323_bb0145","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.2174\/1381612822666160209152033","article-title":"Mitochondrial dysfunction and endoplasmic reticulum stress in diabetes","volume":"22","author":"Rocha","year":"2016","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.metabol.2025.156323_bb0150","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.freeradbiomed.2008.06.019","article-title":"The non-provitamin a carotenoid, lutein, inhibits NF-kappaB-dependent gene expression through redox-based regulation of the phosphatidylinositol 3-kinase\/PTEN\/Akt and NF-kappaB-inducing kinase pathways: role of H(2)O(2) in NF-kappaB activation","volume":"45","author":"Kim","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.metabol.2025.156323_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.671640","article-title":"Cellular mechanisms of liver fibrosis","volume":"12","author":"Acharya","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.metabol.2025.156323_bb0160","doi-asserted-by":"crossref","first-page":"G298","DOI":"10.1152\/ajpgi.00346.2014","article-title":"Micro-RNA 21 inhibition of SMAD7 enhances fibrogenesis via leptin-mediated NADPH oxidase in experimental and human nonalcoholic steatohepatitis","volume":"308","author":"Dattaroy","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.metabol.2025.156323_bb0165","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00592-017-0976-z","article-title":"Suppression of rho-kinase 1 is responsible for insulin regulation of the AMPK\/SREBP-1c pathway in skeletal muscle cells exposed to palmitate","volume":"54","author":"Tang","year":"2017","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.metabol.2025.156323_bb0170","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.metabol.2016.11.001","article-title":"Research advances in metabolism 2016","volume":"67","author":"Perakakis","year":"2017","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2025.156323_bb0175","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1002\/jcb.23137","article-title":"Suppression of LPS-induced inflammatory and NF-kappaB responses by anomalin in RAW 264.7 macrophages","volume":"112","author":"Khan","year":"2011","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.metabol.2025.156323_bb0180","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00011-022-01584-0","article-title":"Inflammatory biomarkers on an LPS-induced RAW 264.7 cell model: a systematic review and meta-analysis","volume":"71","author":"Facchin","year":"2022","journal-title":"Inflamm Res"},{"key":"10.1016\/j.metabol.2025.156323_bb0185","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41598-022-26896-3","article-title":"IL-1beta neutralization prevents diastolic dysfunction development, but lacks hepatoprotective effect in an aged mouse model of NASH","volume":"13","author":"Kucsera","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2025.156323_bb0190","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1053\/j.gastro.2015.12.037","article-title":"Lipid-induced signaling causes release of inflammatory extracellular vesicles from hepatocytes","volume":"150","author":"Hirsova","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2025.156323_bb0195","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4093\/dmj.2021.0197","article-title":"Rho-kinase as a therapeutic target for nonalcoholic fatty liver diseases","volume":"45","author":"Sousa-Lima","year":"2021","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.metabol.2025.156323_bb0200","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1172\/JCI63562","article-title":"Rho-kinase\/AMPK axis regulates hepatic lipogenesis during overnutrition","volume":"128","author":"Huang","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2025.156323_bb0205","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jhep.2018.05.002","article-title":"Towards a definite mouse model of NAFLD","volume":"69","author":"Castro","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2025.156323_bb0210","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41580-022-00547-x","article-title":"New insights into activation and function of the AMPK","volume":"24","author":"Steinberg","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.metabol.2025.156323_bb0215","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.metabol.2010.09.003","article-title":"Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"60","author":"Polyzos","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2025.156323_bb0220","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrgastro.2017.32","article-title":"Lipid droplets and liver disease: from basic biology to clinical implications","volume":"14","author":"Gluchowski","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2025.156323_bb0225","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41419-022-05088-x","article-title":"Oxidative stress-mediated mitochondrial fission promotes hepatic stellate cell activation via stimulating oxidative phosphorylation","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.metabol.2025.156323_bb0230","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1038\/s41467-020-16092-0","article-title":"Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis","volume":"11","author":"An","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2025.156323_bb0235","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jhep.2018.06.008","article-title":"Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease","volume":"69","author":"Lebeaupin","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2025.156323_bb0240","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/iep.12008","article-title":"An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis","volume":"94","author":"Matsumoto","year":"2013","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.metabol.2025.156323_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2024.100634","article-title":"Murine HSD17beta13 does not control liver steatosis and modestly impacts fibrosis in a sex- and diet-specific manner","volume":"65","author":"Crane","year":"2024","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2025.156323_bb0250","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41392-024-01839-8","article-title":"Mitochondrial dysfunction: mechanisms and advances in therapy","volume":"9","author":"Zong","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.metabol.2025.156323_bb0255","article-title":"Fibrosis: cross-organ biology and pathways to development of innovative drugs","author":"Rieder","year":"2025","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.metabol.2025.156323_bb0260","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2025.156323_bb0265","doi-asserted-by":"crossref","first-page":"G1310","DOI":"10.1152\/ajpgi.00365.2011","article-title":"Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2","volume":"302","author":"Miura","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.metabol.2025.156323_bb0270","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrgastro.2010.191","article-title":"Animal models of nonalcoholic fatty liver disease","volume":"8","author":"Hebbard","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2025.156323_bb0275","article-title":"The role of Lipophagy in the development and treatment of non-alcoholic fatty liver disease","volume":"11","author":"Grefhorst","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.metabol.2025.156323_bb0280","doi-asserted-by":"crossref","first-page":"4","DOI":"10.21037\/tgh-20-125","article-title":"Mitochondrial dysfunction in nonalcoholic fatty liver disease and alcohol related liver disease","volume":"6","author":"Prasun","year":"2021","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2025.156323_bb0285","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jhep.2022.09.020","article-title":"Mitochondrial alterations in fatty liver diseases","volume":"78","author":"Fromenty","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2025.156323_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2005.10.004","article-title":"Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it","volume":"6","author":"Begriche","year":"2006","journal-title":"Mitochondrion"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049525001921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049525001921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T05:46:36Z","timestamp":1778564796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049525001921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":58,"alternative-id":["S0026049525001921"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2025.156323","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic effects of C\u2013C chemokine receptor 2 inhibitor and transforming growth factor-\u03b2 type I receptor kinase inhibitor combination in metabolic dysfunction-associated steatohepatitis","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2025.156323","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"156323"}}